查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1401871

2030 年 RNA 定序市场预测：按产品、服务、技术、应用、最终用户和地区进行的全球分析

RNA Sequencing Market Forecasts to 2030 - Global Analysis By Product, Service, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球 RNA 定序市场在预测期内将以 21.4% 的复合年增长率成长。

RNA 定序（也称为 RNA-Seq）是一种基因组方法，用于检测和定量分析生物样本中的信使 RNA 分子，可用于研究细胞反应。 RNA 定序利用高通量定序方法的力量来深入了解细胞的转录组。此方法对于研究基因表现模式、了解细胞过程、识别生物标记以及探索各种研究领域（包括遗传学、基因组学、分子生物学和医学）的疾病机制至关重要。

根据罕见疾病国际组织和 EURORDIS 的数据，罕见疾病目前影响着全球人口的 3.5% 至 5.9%。

精准医疗需求不断成长

RNA测序能够在分子层面上全面分析个体的遗传资讯，在精准医学中发挥重要作用。 RNA 定序有助于识别影响疾病易感性、疾病进展和治疗反应的特定基因突变、基因表现模式和遗传标记。这种全面的知识可以实现个人化的医疗干预，例如标靶治疗和基于个人基因谱的治疗。此外，随着精准医学的加速发展，RNA 定序解释复杂遗传资料的能力变得越来越重要。这将促进 RNA 定序融入临床照护和研究，推动 RNA 定序市场的成长。

资料分析挑战

由于资料量庞大、任务复杂，资料分析的复杂性是RNA定序市场的抑制因素。 RNA-seq资料分析需要先进的计算基础设施、专门的演算法和生物资讯学专业知识来准确解释基因表现模式。跨平台标准化分析方法以确保结果一致是一项挑战，并且会影响资料可靠性。缺乏熟练的分析师和不断发展的工具使这一过程更加复杂。因此，市场需求将受到限制。

生物资讯学创新

生物资讯工具和演算法的进步使得复杂 RNA-seq资料的分析、解释和视觉化变得更加复杂。这些创新提高了资料准确性，并促进基因表现模式、剪接变异体和非编码 RNA 的识别，使研究人员能够获得有意义的生物学见解。此外，改进的软体解决方案简化了资料处理，并使更广泛的用户可以进行分析。持续的生物资讯学创新也促进了新分析方法的发展，促进了RNA定序在不同研究领域、临床诊断和药物开发中更深入的理解和应用。

资料安全和隐私问题

基因组资料的快速成长引发了对诈欺的存取、滥用和敏感遗传资讯外洩的担忧。由于 RNA 定序会产生广泛的个体遗传图谱，因此确保这些资料的机密性和安全处理至关重要。潜在风险包括未经授权的资料存取、资讯盗窃以及共用基因组资讯的道德困境。这些担忧会破坏社会信任，并可能导致对资料共用和使用的监管限制。

COVID-19 的影响

COVID-19 大流行对 RNA 定序市场产生了重大影响。儘管最初遇到供应链中断和实验室限制等障碍，但对 RNA 定序的需求迅速增长。研究人员加速了基因组研究，以了解病毒、开发疫苗并确定潜在的治疗方法。该行业见证了自动化和远端解决方案的发展，以减少操作困难。此外，此次疫情凸显了RNA定序在感染疾病、癌症和个人化医疗研究中的重要性，促进了市场应用和解决方案的持续扩展和多样化。

离子半导体定序领域预计将在预测期内成为最大的领域

据估计，离子半导体序列段所占占有率最大。离子半导体定序是一种 DNA 定序技术，依赖 DNA 聚合过程中产生的氢离子的识别。此技术可检测核苷酸掺入不断生长的 DNA 链时所发生的 pH 值变化。离子半导体定序以其快速处理、经济实惠和适合特定定序应用而闻名。此外，可以透过测量离子浓度的变化来精确识别 DNA 序列，从而实现 RNA 分析以进行基因表现研究、变异检测和理解生物过程。

学术和研究机构部门预计在预测期内复合年增长率最高

学术和研究机构部门预计在预测期内将出现良好成长。学术和研究机构包括积极从事科学研究和基因组研究的教育机构、大学和研究机构。这些机构透过进行基础研究、探索新应用和检验调查方法，在推进 RNA 定序技术方面发挥着至关重要的作用。他们将 RNA 定序用于多种目的，包括破解基因表现模式、识别生物标记、了解疾病机制以及开发治疗性介入。因此，细分市场成长的需求正在增加。

占有率最大的地区

由于精准医疗的日益普及、政府支持基因组研究的倡议以及学术机构和生物技术公司之间研究合作的激增，亚太地区在预测期内占据了最大的市场占有率。测序成本降低、临床诊断应用增加以及主要市场参与企业的存在等因素正在推动市场成长。在个人化医疗需求不断增长和生物资讯学进步的推动下，亚太地区 RNA 定序市场有望持续扩张和创新，塑造该地区医疗保健和生物研究的未来。

复合年增长率最高的地区：

由于 RNA 定序技术的接受度不断提高，预计北美在预测期内将出现有益成长。该地区的特点是广泛的研究活动、雄厚的资金筹措和有利的监管环境。基因组学研究投资的增加、学术机构和行业参与企业之间的合作以及精准医疗的兴起等因素正在推动市场成长。药物研发、诊断和个人化医疗对 RNA 定序的高需求，以及定序技术和资料分析工具的进步，正在推动市场向前发展。

提供免费客製化：

订阅此报告的客户可以利用以下免费自订选项之一：

  • 公司简介
    • 其他市场参与企业的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计/预测/复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 介绍
  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 技术分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球RNA定序市场：副产品

  • 介绍
  • 装置
  • 试剂和套件
  • 其他产品

第六章全球RNA定序市场：依服务分类

  • 介绍
  • RNA定序平台与消耗品
  • 资料分析
  • RNA定序服务
  • 储存与管理
  • 其他服务

第七章全球RNA定序市场：依技术分类

  • 介绍
  • 按组成顺序
  • 奈米孔定序
  • 单分子即时定序
  • 离子半导体序列
  • 其他技术

第八章全球RNA定序市场：依应用分类

  • 介绍
  • 表达谱分析
  • 小RNA定序
  • 从头转录组组装
  • 变异调用
  • 个人化医疗
  • 其他用途

第 9 章 全球 RNA 定序市场：依最终用户划分

  • 介绍
  • 医院和诊断中心
  • 製药和生物技术公司
  • 学术/研究机构
  • 其他最终用户

第10章全球RNA定序市场：按地区

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 中东和非洲其他地区

第十一章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十二章 公司简介

  • Thermo Fischer Scientific
  • Illumina, Tecan Genomics Inc.
  • Agilent Technologies Inc.
  • F. Hoffmann-La Roche Ltd
  • PerkinElmer Inc.
  • GE Healthcare
  • Bio-Rad Laboratories Inc.
  • Eurofins Scientific
  • Sigma Aldrich
  • Admera Health
  • CD Genomics
  • Biogazelle
  • Creative Biogene
  • LC Sciences
  • IGA Technology
  • Lexogen
  • Otogenetics
  • Novogene
  • Yaazh Xenomic
  • Oxford Nanopore Technologies
Product Code: SMRC24391

According to Stratistics MRC, the Global RNA Sequencing Market is growing at a CAGR of 21.4% during the forecast period. RNA sequencing, also known as RNA-Seq, is a genomic approach for the detection and quantitative analysis of messenger RNA molecules in a biological sample and is useful for studying cellular responses. RNA sequencing uses the capabilities of high-throughput sequencing methods to provide insight into the transcriptome of a cell. This method is crucial for studying gene expression patterns, understanding cellular processes, identifying biomarkers, and exploring disease mechanisms in various research areas, including genetics, genomics, molecular biology, and medicine.

According to Rare Diseases International, and EURORDIS, rare diseases currently affect at any point in time 3.5% - 5.9% of the worldwide population; 72% are genetic, of which around 70% start in childhood.

Market Dynamics:

Driver:

Growing demand for precision medicine

RNA sequencing plays a crucial role in precision medicine by enabling comprehensive analysis of an individual's genetic information at the molecular level. Identification of particular genetic variants, patterns of gene expression and genetic markers that impact the susceptibility to disease, its progression, and its response to treatment are rendered easier by it. This comprehensive knowledge makes it possible to implement individualised healthcare interventions, such as targeted therapies and therapies based on a person's genetic profile. Moreover, the capacity of RNA sequencing to interpret complex genetic data has become increasingly essential as precision medicine gains pace. This will encourage the integration of RNA sequencing into clinical care and research, which will fuel market growth for RNA sequencing.

Restraint:

Data analysis challenges

Data analysis complexities pose a restraint in the RNA sequencing market due to the immense data volume and intricacies involved. Analysing RNA sequencing data demands advanced computational infrastructure, specialised algorithms, and bioinformatics expertise to interpret gene expression patterns accurately. Standardising analysis methods across platforms for result consistency is challenging, impacting data reliability. A shortage of skilled analysts and evolving tools further complicate the process. Therefore, it will limit market demand.

Opportunity:

Innovation in bioinformatics

Advancements in bioinformatics tools and algorithms enable more sophisticated analysis, interpretation, and visualisation of complex RNA sequencing data. These innovations enhance data accuracy, facilitate the identification of gene expression patterns, splice variants, and non-coding RNAs, and empower researchers to extract meaningful biological insights. Furthermore, improved software solutions streamline data processing, making analysis more accessible to a wider range of users. Continual bioinformatics innovation also drives the development of novel analytical methods, fostering deeper understanding and application of RNA sequencing in diverse research fields, clinical diagnostics, and drug development.

Threat:

Data security and privacy concerns

The exponential growth in genomic data raises apprehensions about unauthorised access, misuse, and breaches of sensitive genetic information. As RNA sequencing generates extensive personal genetic profiles, ensuring the confidentiality and secure handling of this data becomes paramount. Potential risks include unauthorised data access, identity breaches, and ethical dilemmas related to sharing genomic information. These concerns could erode public trust, resulting in regulatory restrictions on data sharing and utilization.

COVID-19 Impact

The COVID-19 pandemic had a significant impact on the RNA sequencing market. Despite the initial hurdles imposed by disrupted supply chains and restricted laboratories, demand for RNA sequencing quickly increased. Researchers accelerated genomic studies to understand the virus, develop vaccines, and identify potential treatments. The industry witnessed an evolution in the direction of automated and remote solutions to lessen operational difficulties. Furthermore, the pandemic underscored the significance of RNA sequencing in the investigation of infectious diseases, cancer, and personalised medicine, hence promoting sustained expansion and variety in the market's applications and solutions.

The Ion Semiconductor Sequencing segment is expected to be the largest during the forecast period

The Ion Semiconductor Sequencing segment is estimated to hold the largest share. Ion semiconductor sequencing is a technique for sequencing DNA that relies on the identification of hydrogen ions generated during DNA polymerization. This method involves detecting changes in pH levels generated as nucleotides are incorporated into a growing DNA strand. Sequencing from Ion Semiconductor is renowned for its quick processing, affordability, and fit for specific sequencing applications. Additionally, it can precisely identify DNA sequences by measuring changes in ion concentrations, making RNA analysis for gene expression research, variant detection, and comprehending biological processes possible.

The Academic and Research Institutes segment is expected to have the highest CAGR during the forecast period

The Academic and Research Institutes segment is anticipated to have lucrative growth during the forecast period. The Academic and Research Institutes comprise educational institutions, universities, and research organisations actively engaged in scientific investigations and genomic studies. These entities play a pivotal role in advancing RNA sequencing technologies by conducting fundamental research, exploring novel applications, and validating sequencing methodologies. They leverage RNA sequencing for diverse purposes, including deciphering gene expression patterns, identifying biomarkers, understanding disease mechanisms, and developing therapeutic interventions. Thus, there is an increasing demand for segment growth.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period owing to rising adoption of precision medicine, government initiatives supporting genomics research, and a surge in collaborations among academic institutions and biotech firms. Factors like reduced sequencing costs, expanding applications in clinical diagnostics, and the presence of key market players are driving market growth. With growing demand for personalised medicine and advancements in bioinformatics, the Asia-Pacific RNA sequencing market is poised for continuous expansion and innovation, shaping the future of healthcare and biological research in the region.

Region with highest CAGR:

North America is expected to witness profitable growth over the projection period, owing to the rising acceptance for RNA sequencing techniques. It is characterised by extensive research initiatives, robust funding, and a favourable regulatory landscape. Factors such as increasing investments in genomics research, collaborations between academic institutions and industry players, and the prominence of precision medicine drive market growth. The high demand for RNA sequencing in drug discovery, diagnostics, and personalised medicine, along with advancements in sequencing techniques and data analysis tools, propels the market forward.

Key players in the market:

Some of the key players in the RNA Sequencing Market include Thermo Fischer Scientific, Illumina, Tecan Genomics Inc., Agilent Technologies Inc., F. Hoffmann-La Roche Ltd, PerkinElmer Inc., GE Healthcare, Bio-Rad Laboratories Inc., Eurofins Scientific, Sigma Aldrich, Admera Health, CD Genomics, Biogazelle, Creative Biogene, LC Sciences, IGA Technology , Lexogen, Otogenetics, Novogene, Yaazh Xenomic and Oxford Nanopore Technologies.

Key Developments:

In August 2023, Thermo Fisher Scientific, the world leader in serving science, announced the launch of a new chromosomal microarray designed to improve cytogenetic research lab productivity, efficiency and profitability with an industry-leading two-day turnaround time.

In May 2023, Thermo Fisher Scientific, the world leader in serving science, expanded its manufacturing capacity in St. Louis to support biologic therapies for diseases ranging from cancers to auto immune conditions to rare genetic disorders.

In March 2021, Thermo Fisher Scientific Inc., declared the introduction of the Thermo Scientific Aerosol Sense Sampler, a novel surveillance solution planned to transfer speedy and greatly trustworthy insight into the existence of in-air pathogens, inclusive of SARS-CoV-2. Individual testing will persist in being essential in the COVID-19 pandemic response owing to its ability to allow and apprise clinical diagnoses, patient triage, and treatment decisions.

Products Covered:

  • Instruments
  • Reagents & Kits
  • Other Products

Services Covered:

  • RNA Sequencing Platforms & Consumables
  • Data Analysis
  • RNA Sequencing Services
  • Storage And Management
  • Other Services

Technologies Covered:

  • Sequencing by Synthesis
  • Nanopore Sequencing
  • Single Molecule Real Time Sequencing
  • Ion Semiconductor Sequencing
  • Other Technologies

Applications Covered:

  • Expression Profiling Analysis
  • Small RNA Sequencing
  • De Novo Transcriptome Assembly
  • Variant Calling
  • Personalized Medicine
  • Other Applications

End Users Covered:

  • Hospitals and Diagnostic Centers
  • Pharmaceutical & Biotechnology Companies
  • Academic and Research Institutes
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global RNA Sequencing Market, By Product

  • 5.1 Introduction
  • 5.2 Instruments
  • 5.3 Reagents & Kits
  • 5.4 Other Products

6 Global RNA Sequencing Market, By Services

  • 6.1 Introduction
  • 6.2 RNA Sequencing Platforms & Consumables
  • 6.3 Data Analysis
  • 6.4 RNA Sequencing Services
  • 6.5 Storage And Management
  • 6.6 Other Services

7 Global RNA Sequencing Market, By Technology

  • 7.1 Introduction
  • 7.2 Sequencing by Synthesis
  • 7.3 Nanopore Sequencing
  • 7.4 Single Molecule Real Time Sequencing
  • 7.5 Ion Semiconductor Sequencing
  • 7.6 Other Technologies

8 Global RNA Sequencing Market, By Application

  • 8.1 Introduction
  • 8.2 Expression Profiling Analysis
  • 8.3 Small RNA Sequencing
  • 8.4 De Novo Transcriptome Assembly
  • 8.5 Variant Calling
  • 8.6 Personalized Medicine
  • 8.7 Other Applications

9 Global RNA Sequencing Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals and Diagnostic Centers
  • 9.3 Pharmaceutical & Biotechnology Companies
  • 9.4 Academic and Research Institutes
  • 9.5 Other End Users

10 Global RNA Sequencing Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Thermo Fischer Scientific
  • 12.2 Illumina, Tecan Genomics Inc.
  • 12.3 Agilent Technologies Inc.
  • 12.4 F. Hoffmann-La Roche Ltd
  • 12.5 PerkinElmer Inc.
  • 12.6 GE Healthcare
  • 12.7 Bio-Rad Laboratories Inc.
  • 12.8 Eurofins Scientific
  • 12.9 Sigma Aldrich
  • 12.10 Admera Health
  • 12.11 CD Genomics
  • 12.12 Biogazelle
  • 12.13 Creative Biogene
  • 12.14 LC Sciences
  • 12.15 IGA Technology
  • 12.16 Lexogen
  • 12.17 Otogenetics
  • 12.18 Novogene
  • 12.19 Yaazh Xenomic
  • 12.20 Oxford Nanopore Technologies

List of Tables

  • Table 1 Global RNA Sequencing Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global RNA Sequencing Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global RNA Sequencing Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 4 Global RNA Sequencing Market Outlook, By Reagents & Kits (2021-2030) ($MN)
  • Table 5 Global RNA Sequencing Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 6 Global RNA Sequencing Market Outlook, By Services (2021-2030) ($MN)
  • Table 7 Global RNA Sequencing Market Outlook, By RNA Sequencing Platforms & Consumables (2021-2030) ($MN)
  • Table 8 Global RNA Sequencing Market Outlook, By Data Analysis (2021-2030) ($MN)
  • Table 9 Global RNA Sequencing Market Outlook, By RNA Sequencing Services (2021-2030) ($MN)
  • Table 10 Global RNA Sequencing Market Outlook, By Storage And Management (2021-2030) ($MN)
  • Table 11 Global RNA Sequencing Market Outlook, By Other Services (2021-2030) ($MN)
  • Table 12 Global RNA Sequencing Market Outlook, By Technology (2021-2030) ($MN)
  • Table 13 Global RNA Sequencing Market Outlook, By Sequencing by Synthesis (2021-2030) ($MN)
  • Table 14 Global RNA Sequencing Market Outlook, By Nanopore Sequencing (2021-2030) ($MN)
  • Table 15 Global RNA Sequencing Market Outlook, By Single Molecule Real Time Sequencing (2021-2030) ($MN)
  • Table 16 Global RNA Sequencing Market Outlook, By Ion Semiconductor Sequencing (2021-2030) ($MN)
  • Table 17 Global RNA Sequencing Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 18 Global RNA Sequencing Market Outlook, By Application (2021-2030) ($MN)
  • Table 19 Global RNA Sequencing Market Outlook, By Expression Profiling Analysis (2021-2030) ($MN)
  • Table 20 Global RNA Sequencing Market Outlook, By Small RNA Sequencing (2021-2030) ($MN)
  • Table 21 Global RNA Sequencing Market Outlook, By De Novo Transcriptome Assembly (2021-2030) ($MN)
  • Table 22 Global RNA Sequencing Market Outlook, By Variant Calling (2021-2030) ($MN)
  • Table 23 Global RNA Sequencing Market Outlook, By Personalized Medicine (2021-2030) ($MN)
  • Table 24 Global RNA Sequencing Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 25 Global RNA Sequencing Market Outlook, By End User (2021-2030) ($MN)
  • Table 26 Global RNA Sequencing Market Outlook, By Hospitals and Diagnostic Centers (2021-2030) ($MN)
  • Table 27 Global RNA Sequencing Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
  • Table 28 Global RNA Sequencing Market Outlook, By Academic and Research Institutes (2021-2030) ($MN)
  • Table 29 Global RNA Sequencing Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.